Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis
D Pastori, A Farcomeni, A Milanese… - Thrombosis and …, 2020 - thieme-connect.com
Background Statins are guidelines recommended in patients with peripheral artery disease
(PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the …
(PAD) for the prevention of cardiovascular (CV) events. Comprehensive meta-data on the …
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
Aims Due to a high burden of systemic cardiovascular events, current guidelines
recommend the use of statins in all patients with peripheral artery disease (PAD). We sought …
recommend the use of statins in all patients with peripheral artery disease (PAD). We sought …
Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis
GA Antoniou, RK Fisher, GS Georgiadis… - Vascular …, 2014 - Elsevier
Objective To investigate and analyse the existing evidence supporting statin therapy in
patients with lower limb atherosclerotic arterial disease. Methods A systematic search of …
patients with lower limb atherosclerotic arterial disease. Methods A systematic search of …
[HTML][HTML] Statins and statin intensity in peripheral artery disease
Background: Peripheral artery disease (PAD) affects more than 202 million people
worldwide. Several studies have shown that patients with PAD are often undertreated, and …
worldwide. Several studies have shown that patients with PAD are often undertreated, and …
Statins and peripheral arterial disease: a narrative review
S Jansen-Chaparro, MD López-Carmona… - Frontiers in …, 2021 - frontiersin.org
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …
Association of statin dose with amputation and survival in patients with peripheral artery disease
Background: Statin dose guidelines for patients with peripheral artery disease (PAD) are
largely based on coronary artery disease and stroke data. The aim of this study is to …
largely based on coronary artery disease and stroke data. The aim of this study is to …
Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis
DG Kokkinidis, A Arfaras-Melainis… - Vascular …, 2020 - journals.sagepub.com
High-intensity statins are recommended for patients with peripheral artery disease (PAD).
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …
Critical limb ischemia (CLI) is the most advanced presentation of PAD. The benefit of statins …
[HTML][HTML] Statin use in patients with peripheral arterial disease
SK Harris, MG Roos, GJ Landry - Journal of vascular surgery, 2016 - Elsevier
Background Statins are recommended for use in patients with peripheral arterial disease
(PAD) to reduce cardiovascular events and mortality. However, much of the data regarding …
(PAD) to reduce cardiovascular events and mortality. However, much of the data regarding …
[HTML][HTML] Statin use improves limb salvage after intervention for peripheral arterial disease
GM Parmar, Z Novak, E Spangler, M Patterson… - Journal of vascular …, 2019 - Elsevier
Background Statin use is recommended in all patients with peripheral arterial disease (PAD)
owing to its morbidity and mortality benefits. However, the effect of statin use on limb salvage …
owing to its morbidity and mortality benefits. However, the effect of statin use on limb salvage …
Peripheral arterial disease: a missed opportunity to administer statins so as to reduce cardiac morbidity and mortality
SS Daskalopoulou, ME Daskalopoulos… - Current medicinal …, 2005 - ingentaconnect.com
Peripheral arterial disease (PAD) is a common condition associated with an increased risk
of coronary heart disease, myocardial infarction and stroke. It follows that PAD merits …
of coronary heart disease, myocardial infarction and stroke. It follows that PAD merits …